Laverock Therapeutics
Stevenage · Founded 2022
About Laverock Therapeutics
Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.7M
- Funding stage: Seed
- Last round: Seed (Jun 2025)
- Website: https://www.laverocktx.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/laverock-therapeutics-79570 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.